These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35943666)

  • 1. Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease.
    Gliwińska A; Ćwiklińska A; Czaplińska M; Wieczorek-Breitzke E; Kortas-Stempak B; Kuchta A; Dębska-Ślizień A; Król E; Jankowski M
    J Nephrol; 2023 Jan; 36(1):115-124. PubMed ID: 35943666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Levels of Preβ1-HDL Are Significantly Elevated in Non-Dialyzed Patients with Advanced Stages of Chronic Kidney Disease.
    Kuchta A; Ćwiklińska A; Czaplińska M; Wieczorek E; Kortas-Stempak B; Gliwińska A; Dąbkowski K; Sałaga-Zaleska K; Mickiewicz A; Dębska-Ślizień A; Król E; Jankowski M
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease.
    Cheung MC; Brown BG; Wolf AC; Albers JJ
    J Lipid Res; 1991 Mar; 32(3):383-94. PubMed ID: 1906084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
    Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
    J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.
    Ćwiklińska A; Cackowska M; Wieczorek E; Król E; Kowalski R; Kuchta A; Kortas-Stempak B; Gliwińska A; Dąbkowski K; Zielińska J; Dębska-Ślizień A; Jankowski M
    Kidney Blood Press Res; 2018; 43(3):970-978. PubMed ID: 29913451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the human cholesteryl ester transfer protein on the particle size redistribution of specific subpopulations of high density lipoproteins-3.
    Lagrost L
    Biochim Biophys Acta; 1992 Jun; 1126(2):143-50. PubMed ID: 1627616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High density lipoprotein (HDL) particle composition in patients with end stage renal failure (ESRF) on chronic dialysis.
    Lee P; O'Neal D; Murphy B; Best J
    Aust N Z J Med; 1997 Jun; 27(3):285-93. PubMed ID: 9227812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease.
    Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shibata T
    J Atheroscler Thromb; 2016; 23(1):81-94. PubMed ID: 26289085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preβ1-high-density lipoprotein metabolism is delayed in patients with chronic kidney disease not on hemodialysis.
    Yamatani K; Hirayama S; Seino U; Hirayama A; Hori A; Suzuki K; Idei M; Kitahara M; Miida T
    J Clin Lipidol; 2020; 14(5):730-739. PubMed ID: 32868248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease.
    Asztalos BF; Roheim PS; Milani RL; Lefevre M; McNamara JR; Horvath KV; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2670-6. PubMed ID: 11116070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles.
    Krimbou L; Marcil M; Chiba H; Genest J
    J Lipid Res; 2003 May; 44(5):884-92. PubMed ID: 12611904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of new HDL particles from lipid-free apolipoprotein A-I.
    Clay MA; Barter PJ
    J Lipid Res; 1996 Aug; 37(8):1722-32. PubMed ID: 8864956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease.
    Rysz-Gorzynska M; Gluba-Brzozka A; Banach M
    Curr Vasc Pharmacol; 2017; 15(2):144-151. PubMed ID: 27697068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage interaction of HDL subclasses separated by free flow isotachophoresis.
    Nowicka G; Brüning T; Böttcher A; Kahl G; Schmitz G
    J Lipid Res; 1990 Nov; 31(11):1947-63. PubMed ID: 2086694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.
    Marsche G; Heine GH; Stadler JT; Holzer M
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32967334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High density lipoproteins and reverse cholesterol transport: lessons from mutations.
    von Eckardstein A; Assmann G
    Atherosclerosis; 1998 Apr; 137 Suppl():S7-11. PubMed ID: 9694535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
    Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
    Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.